Tumour angiogenesis and response in combined modality treatment of head and neck cancer

1999 ◽  
Vol 35 ◽  
pp. S105
Author(s):  
E. Dobrowsky ◽  
S. Lang ◽  
W. Dobrowsky
1984 ◽  
Vol 2 (7) ◽  
pp. 804-810 ◽  
Author(s):  
S H Krasnow ◽  
M H Cohen ◽  
A Johnston-Early ◽  
M L Citron ◽  
B E Fossieck ◽  
...  

As part of a combined modality treatment program using chemotherapy, surgery, and/or radiotherapy, 25 patients with previously untreated stage III or IV head and neck cancer received initial combination chemotherapy. Pathologically confirmed complete remission was noted in nine patients (36%). The overall objective major response rate (with all patients included in analysis) was 68%. The chemotherapy regimen included bleomycin, cisplatin, vinblastine, methotrexate, and 5-fluorouracil. A novel concept of drug scheduling was used, based on chemotherapy-induced improvement in RBC deformability. The underlying concept is that improved RBC deformability results in improved capillary blood flow and thereby, increased drug delivery to tumor cells. Treatment resulted in moderate hematologic and renal toxicity with no treatment-related deaths. This exceptionally high, pathologically confirmed complete response rate will hopefully provide a mechanism by which combined modality therapy can adequately be tested for its ability to prolong survival of patients with advanced head and neck cancer.


Cancer ◽  
1985 ◽  
Vol 55 (S9) ◽  
pp. 2149-2155 ◽  
Author(s):  
Ralph R. Weichselbaum ◽  
John R. Clark ◽  
Daniel Miller ◽  
Marshall R. Posner ◽  
Thomas J. Ervin

Sign in / Sign up

Export Citation Format

Share Document